Showing 2,321 - 2,340 results of 16,814 for search '"cancer"', query time: 0.13s Refine Results
  1. 2321
  2. 2322

    Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer by Wan-Xin Peng, Pratirodh Koirala, Huaixiang Zhou, Jiahong Jiang, Ziqiang Zhang, Liu Yang, Yin-Yuan Mo

    Published 2021-10-01
    “…Abstract Selective estrogen receptor modulators (SERMs) such as tamoxifen have proven to be effective in the treatment of estrogen receptor (ER) positive breast cancer. However, a major obstacle for such endocrine therapy is estrogen independent growth, leading to resistance, and the underlying mechanism is not fully understood. …”
    Get full text
    Article
  3. 2323
  4. 2324

    Manganese-Enhanced Magnetic Resonance Imaging for Early Detection and Characterization of Breast Cancers by Mosa Alhamami, Reza Bayat Mokhtari, Tameshwar Ganesh, Joris Tchouala Nofiele, Herman Yeger, Hai-Ling Margaret Cheng

    Published 2014-09-01
    “…Very early cancer detection is the key to improving cure. Our objective was to investigate manganese (Mn)-enhanced magnetic resonance imaging (MRI) for very early detection and characterization of breast cancers. …”
    Get full text
    Article
  5. 2325

    Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer by Lei Wang, Liping Liang, Shuzhen Shi, Chao Wang

    Published 2022-01-01
    “…The aim of this study was to use the drug carrier dextran/polylactic acid (DEX/PLA) and paramagnetic Fe3O4 to improve the targeting of DOX in liver cancer treatment while reducing its potential organ toxicity. …”
    Get full text
    Article
  6. 2326
  7. 2327
  8. 2328

    The Prediction of Necroptosis-Related lncRNAs in Prognosis and Anticancer Therapy of Colorectal Cancer by Hanyu Xiao, Qidan Pang, Yong Wang, Suhe Lai, Hong Chen

    Published 2022-01-01
    “…Background. Colorectal cancer is one of the most common gastrointestinal malignancies globally. …”
    Get full text
    Article
  9. 2329
  10. 2330

    Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies by Sandro Matosevic

    Published 2018-01-01
    “…Here, we discuss the genetic engineering of NK cells as they relate to NK immunobiology within the context of cancer immunotherapy, highlighting the most recent breakthroughs in viral vectors and nonviral approaches aimed at genetic reprogramming of NK cells for improved adoptive immunotherapy of cancer, and, finally, address their clinical status.…”
    Get full text
    Article
  11. 2331
  12. 2332
  13. 2333

    Use of Magnetic Nanoparticles as Targeted Therapy: Theranostic Approach to Treat and Diagnose Cancer by Arif Malik, Tariq Tahir Butt, Sara Zahid, Fatima Zahid, Sulayman Waquar, Mahmood Rasool, Mahmood Husain Qazi, Aamer Mahmood Qazi

    Published 2017-01-01
    “…The metastasis of cancer epitomizes the diagnostic and therapeutic challenge as a result of cancer heterogeneity. …”
    Get full text
    Article
  14. 2334
  15. 2335
  16. 2336

    Crosstalk between Gut Microbiota and Cancer Immunotherapy: Present Investigations and Future Perspective by Yuhui Tang, Qiaoting Cai, Zhi Tian, Wenkuan Chen, Hailin Tang

    Published 2025-01-01
    “…Gut microbiota is crucial for protecting the homeostasis of immune locally and systemically, and its dysbiosis is essentially correlated to tumorigenesis, cancer progression, and refractoriness to cancer treatments, including the novel immunotherapy. …”
    Get full text
    Article
  17. 2337

    Advances in Surface Plasmon Resonance-Based Biosensor Technologies for Cancer Cell Detection by Bhishma Karki, Arun Uniyal, Amrindra Pal, Vivek Srivastava

    Published 2022-01-01
    “…Using the finite element method-based simulation technique, the sensitivity obtained as 195.4 degree/RIU, 167.6 degree/RIU, 212.4 degree/RIU, 168.4 degree/RIU, 212.4 degree/RIU, 186.6 degree/RIU, 218.6 degree/RIU, 195.4 degree/RIU, 203.6 degree/RIU, 202.6 degree/RIU 203.6 degree/RIU, and 202.6 for basal (skin cancer), basal (normal cell), HeLa (cervical cancer), MCF-7 (breast cancer), HeLa (normal cell), Jurkat (blood cancer), Jurkat (normal cell), PCI-2 (adrenal gland cancer), PCI-2 (normal cell), MDA-MB-231 (breast cancer), MDA-MB-231 (normal cell), MCF-7 (breast cancer), and MCF-7 (normal cell), respectively, and other performance parameters such as detection accuracy, figure of merit, and full width and half maximum (FWHM) are also evaluated.…”
    Get full text
    Article
  18. 2338

    Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer by Maria E. Pretorius, Håkon Wæhre, Vera M. Abeler, Ben Davidson, Ljiljana Vlatkovic, Ragnhild A. Lothe, Karl-Erik Giercksky, Håvard E. Danielsen

    Published 2009-01-01
    “…Background: The clinical outcome for the individual prostate cancer patient is often difficult to predict, due to lack of reliable independent prognostic biomarkers. …”
    Get full text
    Article
  19. 2339

    Relationship of modifiable risk factors with the incidence of thyroid cancer: a worldwide study by Zahra Maleki, Jafar Hassanzadeh, Haleh Ghaem

    Published 2025-01-01
    “…Abstract Background Thyroid cancer is one of the most common cancers of the endocrine system. …”
    Get full text
    Article
  20. 2340